
Cytek Biosciences (CTKB) Stock Forecast & Price Target
Cytek Biosciences (CTKB) Analyst Ratings
Based on 5 analyst ratings
Hold
Strong Buy 20%
Buy 40%
Hold 20%
Sell 0%
Strong Sell 20%
Cytek Biosciences (CTKB) has been analyzed by 5 analysts, with a consensus rating of Hold. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 20% suggest Holding, 0% advise Selling, and 20% predict a Strong Sell.
This aggregate rating is based on analysts' research of Cytek Biosciences and is not a guaranteed prediction by Public.com or investment advice.
This aggregate rating is based on analysts' research of Cytek Biosciences and is not a guaranteed prediction by Public.com or investment advice.
Cytek Biosciences (CTKB) Analyst Forecast & Price Prediction
Get the latest Cytek Biosciences (CTKB) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Start investing in Cytek Biosciences (CTKB)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Cytek Biosciences (CTKB) Forecast
Analysts have given Cytek Biosciences (CTKB) a Hold based on their latest research and market trends.
According to 5 analysts, Cytek Biosciences (CTKB) has a Hold consensus rating as of Jan 10, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.
Wall Street analysts have set a price target of $5.70, reflecting a 0.00% increase from the current stock price.
Financial analysts have set a price target of $5.70, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.